United States - English - NLM (National Library of Medicine)

neogen corporation - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol injection 20% is indicated for use as an osmotic diuretic in canine species. mannitol is essentially inert metabolically. when given parenterally, it is freely filtered at the glomerulus which produces osmotic diuresis as more than 90% of the mannitol injected escapes reabsorption.

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mannitol - solution for infusion - mannitol 100 mg/ml - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mannitol - solution for infusion - mannitol 150 mg/ml - blood substitutes and perfusion solutions

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - mannitol - solution for infusion - 20 per cent

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

10%) infusion viaflo bags (baxter healthcare ltd - mannitol - infusion - 100mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15%) infusion viaflo bags (baxter healthcare ltd - mannitol - infusion - 150mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mannitol, quantity: 200 g/l - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.

New Zealand - English - Medsafe (Medicines Safety Authority)

paragon care group new zealand limited t/a rem systems - mannitol 10% - solution for infusion - 10 % - active: mannitol 10%

New Zealand - English - Medsafe (Medicines Safety Authority)

paragon care group new zealand limited t/a rem systems - mannitol 20% - solution for infusion - 20 % - active: mannitol 20% excipient: water for injection

United States - English - NLM (National Library of Medicine)

doctor hoy's, llc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941) - menthol 50 mg in 1 ml - uses: for the temporary relief of minor aches and pains of muscles and joints due to: * simple backache * arthritis * sprains * strains * bruises directions: for adults and children 2 years and older; apply to affected area not more than 3 to 4 times daily. "children under 2 years of age: consult a doctor."  apply generously to affected and surrounding areas.  rub in well. use 1 application for minor pain, 2 for medium and 3 applications for severs symptoms.  allow to dry between applications (usually just 2-3 minutes). uses: for the temporary relief of minor aches and pains of muscles and joints due to:     * simple backache     * arthritis     * sprains     * strains     * bruises